M. Tish Knobf

Sep 22, 2023 | hindawi.com | Peng Yun Chen |Ying Tang |Xiao Tang |Alex Molassiotis |M. Tish Knobf |Guang Hu | +3 more

Background. Prediction of high-risk depression trajectories in the first year following breast cancer diagnosis with fMRI-related brain connectomics is unclear. Methods. The Be Resilient to Breast Cancer (BRBC) study is a multicenter trial in which 189/232 participants (81.5%) completed baseline resting-state functional magnetic resonance imaging (rs-fMRI) and four sequential assessments of depression (T0-T3).